BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38734198)

  • 1. Effects of iron supplements in individuals with erythropoietic protoporphyria.
    Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
    Photodiagnosis Photodyn Ther; 2024 May; 47():104211. PubMed ID: 38734198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria.
    Balwani M; Naik H; Overbey JR; Bonkovsky HL; Bissell DM; Wang B; Phillips JD; Desnick RJ; Anderson KE
    Mol Genet Metab Rep; 2022 Dec; 33():100939. PubMed ID: 36406817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine for erythropoietic protoporphyria.
    Heerfordt IM; Lerche CM; Wulf HC
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102793. PubMed ID: 35245673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
    Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
    J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcytosis in Erythropoietic Protoporphyria.
    Graziadei G; Duca L; Granata F; De Luca G; De Giovanni A; Brancaleoni V; Nava I; Di Pierro E
    Front Physiol; 2022; 13():841050. PubMed ID: 35309058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
    Delaby C; Lyoumi S; Ducamp S; Martin-Schmitt C; Gouya L; Deybach JC; Beaumont C; Puy H
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):45-52. PubMed ID: 19268001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
    Schmidt PJ; Hollowell ML; Fitzgerald K; Butler JS; Fleming MD
    Am J Hematol; 2020 May; 95(5):492-496. PubMed ID: 31990410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up.
    Heerfordt IM; Lerche CM; Wulf HC
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101928. PubMed ID: 32717453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.
    Di Pierro E; Granata F; De Canio M; Rossi M; Ricci A; Marcacci M; De Luca G; Sarno L; Barbieri L; Ventura P; Graziadei G
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
    Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
    Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
    J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of protoporphyrin IX in erythrocytes in a case of acquired erythropoietic protoporphyria.
    Heerfordt IM; Fontenete S; Lerche CM; Wulf HC
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102629. PubMed ID: 34798346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostasis of iron and hepcidin in erythropoietic protoporphyria.
    Bossi K; Lee J; Schmeltzer P; Holburton E; Groseclose G; Besur S; Hwang S; Bonkovsky HL
    Eur J Clin Invest; 2015 Oct; 45(10):1032-41. PubMed ID: 26199063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.
    Genovese G; Maronese CA; Moltrasio C; Piccinno R; Marletta DA; De Luca G; Graziadei G; Granata F; Di Pierro E; Cappellini MD; Marzano AV
    Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):141-149. PubMed ID: 34420239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An explorative study of non-invasive ultra-weak photon emission and the anti-oxidative influence of oral zinc sulphate in light-sensitive patients with erythropoietic protoporphyria.
    Petersen AB; Philipsen PA; Wulf HC
    Skin Res Technol; 2012 Nov; 18(4):405-12. PubMed ID: 22092997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria.
    Heerfordt IM; Wulf HC
    Br J Dermatol; 2016 Dec; 175(6):1284-1289. PubMed ID: 27603594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
    Barman-Aksözen J; Halloy F; Iyer PS; Schümperli D; Minder AE; Hall J; Minder EI; Schneider-Yin X
    Mol Genet Metab; 2019 Nov; 128(3):304-308. PubMed ID: 31076252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of erythropoietic protoporphyria with cholestatic liver disease: A case report.
    Poli A; Frieri C; Lefebvre T; Delforge J; Mirmiran A; Talbi N; Moulouel B; Six M; Paradis V; Parquet N; Puy H; Schmitt C; Aslangul E; de Fontbrune FS; Gouya L
    Mol Genet Metab Rep; 2023 Dec; 37():101018. PubMed ID: 38053924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.